ReviewJournal of translational medicine2025
Low-intensity pulsed ultrasound for peripheral nerve regeneration: mechanobiological mechanisms and translational potential.
Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The progress of mitochondrial function and transfer in stem cell regulation and therapy.Journal of physiology and biochemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeripheral nerve injury (PNI) remains a major clinical challenge, often resulting in incomplete functional recovery despite advances in microsurgical repair. Low-intensity pulsed ultrasound (LIPUS) has recently gained attention as a noninvasive biophysical therapy capable of enhancing nerve regeneration through mechanical stimulation and cellular activation. MAIN BODY: This review synthesizes current preclinical evidence on the effects of LIPUS across in vitro and in vivo models and outlines its underlying mechanobiological mechanisms and translational implications. A systematic search identified thirty-four experimental studies evaluating LIPUS in nerve injury models, including crush, transection, autograft, and conduit repair. Collectively, these studies demonstrate that LIPUS accelerates axonal regeneration, promotes remyelination, enhances Schwann cell proliferation and migration, and increases neurotrophic factor expression. LIPUS also facilitates neural stem cell differentiation and neuronal survival by activating key intracellular signaling pathways. Despite encouraging preclinical results, significant challenges remain in translating LIPUS to clinical practice. Variability in stimulation parameters, injury models, and species hampers reproducibility, and regulatory approval for neural applications is still pending. Future research should focus on standardizing dosimetry, validating mechanistic pathways in human tissues, and conducting multicenter clinical trials to establish safety, efficacy, and practical treatment guidelines. SHORT
conclusionThe current evidence supports LIPUS as a safe and adaptable mechanotransductive therapy that can modulate cellular behavior and molecular signaling to enhance peripheral nerve regeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.